Ospedale San Carlo di Nancy
Ospedale San Carlo di Nancy
Italy, Rome
Alessandro Calarco
19 years of experience
Clinic is certified :
Why choose Italy for holmium laser enucleation of the prostate?
Access advanced Holmium Laser Enucleation of the Prostate solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Holmium Laser Enucleation of the Prostate | - | from $3,000 | from $7,500 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Holmium Laser Enucleation of the Prostate upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Holmium Laser Enucleation of the Prostate and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Holmium Laser Enucleation of the Prostate journey.
Day 1: Arrival
Day 2: Pre-operation
Day 3: Operation
Day 4: Post-operation
Day 5-7: Recovery at the hotel
Week 2-4: Rehabilitation
Week 5: Return to work
Note: Each patient"s recovery process may vary based on individual health conditions and the complexity of the operation.
Over 8,000 urology surgeries performed – Prof. Montorsi is a top Italian expert in minimally invasive and robotic techniques at San Raffaele.
Specializes in minimally invasive prostate treatments – Dr. Saltutti uses robotic and laparoscopic techniques at Maria Cecilia Hospital.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.